Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3446627 | Archives of Medical Research | 2014 | 5 Pages |
Abstract
Olmesartan treatment was found to generate beneficial effects on MetS parameters in HT patients but did not produce any significant increases in serum PPAR-γ transcription factor concentration.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ãmer Akyürek, Erdem Akbal, Fahri GüneÅ, Nesibe Akyürek,